Optimizing COVID‐19 Candidate Therapeutics: Thinking Without Borders

par Rayner, Craig R., Smith, Patrick F., Hershberger, Kevin, Wesche, David
Publié dans Clin Transl Sci (2020)

Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa

par Bergen, Phillip J., Li, Jian, Rayner, Craig R., Nation, Roger L.
Publié 2006

Pharmacokinetic/Pharmacodynamic Factors Influencing Emergence of Resistance to Linezolid in an In Vitro Model

par Boak, Lauren M., Li, Jian, Rayner, Craig R., Nation, Roger L.
Publié 2007

Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID‐19

par Hartman, Dan, Kern, Steven, Brown, Fran, Minton, Suzanne K., Rayner, Craig R.
Publié dans Clin Transl Sci (2020)

Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients

par Wallace, Stephanie J., Li, Jian, Rayner, Craig. R., Coulthard, Kingsley, Nation, Roger L.
Publié 2008

Early Treatment of COVID-19 Disease: A Missed Opportunity

par Forrest, Jamie I., Rayner, Craig R., Park, Jay J. H., Mills, Edward J.
Publié dans Infect Dis Ther (2020)

Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity

par Forrest, Jamie I., Rayner, Craig R., Park, Jay J. H., Mills, Edward J.
Publié dans Infect Dis Ther (2020)

Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program

par Meagher, Alison K., Forrest, Alan, Rayner, Craig R., Birmingham, Mary C., Schentag, Jerome J.
Publié 2003

Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience

par Smith, James R., Rayner, Craig R., Donner, Barbara, Wollenhaupt, Martina, Klumpp, Klaus, Dutkowski, Regina
Publié dans Adv Ther (2011)

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted

par Park, Jay J H, Decloedt, Eric H, Rayner, Craig R, Cotton, Mark, Mills, Edward J
Publié dans Lancet Glob Health (2020)

Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response

par Dobrovolny, Hana M., Reddy, Micaela B., Kamal, Mohamed A., Rayner, Craig R., Beauchemin, Catherine A. A.
Publié 2013

The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19

par Lee, Zelyn, Rayner, Craig R., Forrest, Jamie I., Nachega, Jean B., Senchaudhuri, Esha, Mills, Edward J.
Publié dans Am J Trop Med Hyg (2021)

Initial Concentration-Time Profile of Gentamicin Determines Efficacy against Enterobacter cloacae ATCC 13047

par Rayner, Craig R., Ioannides-Demos, Lisa L., Brien, Jo-Anne E., Liolios, Lisa L., Spicer, W. John
Publié 1998

Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma

par Sudhakaran, Sreeja, Rayner, Craig R, Li, Jian, Kong, David C M, Gude, Neil M, Nation, Roger L
Publié 2007

Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus

par Sudhakaran, Sreeja, Rayner, Craig R, Li, Jian, Kong, David C M, Gude, Neil M, Nation, Roger L
Publié 2008

Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii

par Li, Jian, Rayner, Craig R., Nation, Roger L., Owen, Roxanne J., Spelman, Denis, Tan, Kar Eng, Liolios, Lisa
Publié 2006

Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis

par Patel, Kashyap, Rayner, Craig R, Giraudon, Mylène, Kamal, Mohamed A, Morcos, Peter N, Robson, Richard, Kirkpatrick, Carl M
Publié dans Br J Clin Pharmacol (2015)

A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression

par Kamal, Mohamed A., Gieschke, Ronald, Lemenuel-Diot, Annabelle, Beauchemin, Catherine A. A., Smith, Patrick F., Rayner, Craig R.
Publié dans Antimicrob Agents Chemother (2015)

Investigating Clinically Adequate Concentrations of Oseltamivir Carboxylate in End-Stage Renal Disease Patients Undergoing Hemodialysis Using a Population Pharmacokinetic Approach

par Kamal, Mohamed A., Lien, Kayla Yi Ting, Robson, Richard, Subramoney, Vishak, Clinch, Barry, Rayner, Craig R., Gibiansky, Leonid
Publié dans Antimicrob Agents Chemother (2015)

Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression

par Kamal, Mohamed A., Gieschke, Ronald, Lemenuel-Diot, Annabelle, Beauchemin, Catherine A. A., Smith, Patrick F., Rayner, Craig R.
Publié dans Antimicrob Agents Chemother (2016)